MFs close in gap with bank deposit on back of strong growth, new investor addition

Thanks to uninterrupted bull run and renewed interest in equity investment, the quantum of assets under management of the mutual fund industry accounts for 26 per cent of the bank deposit as of March-end against 21 per cent logged in FY23.

Thanks to uninterrupted bull run and renewed interest in equity investment, the quantum of assets under management of the mutual fund industry accounts for 26 per cent of the bank deposit as of March-end against 21 per cent logged in FY23.

Also read:ETFs trade like small-cap stocks as SEBI bans MFs’ overseas investment While bank deposits have increased 13 per cent last fiscal to ₹205 lakh crore, the mutual fund industry has registered 35 per cent growth in AUM to ₹53.40 lakh crore on the back of sharp increase in inflow and addition of new investors.

The equity AUM alone has jumped 48 per cent to ₹39 lakh crore (₹26.60 lakh crore) even as the inflows dipped 22 per cent to ₹2.37 lakh crore (₹3.02 lakh crore).

The number of unique investors (identified by PAN number) added by the MF industry has increased by 69 lakh or 18 per cent to 4.46 crore in FY24.

Of the overall AUM of the MF industry, individual investors account for 61 per cent against 58 per cent in FY23 while institutional investors share was down at 39 per cent against 42 per cent, according to Franklin Templeton study.

With the sharp run in equity markets, the industry has managed to reach beyond top-30 cities to attract new investors especially through the monthly systematic investment plan.

The Systematic Investment Plan inflows were up 28 per cent at ₹2 lakh crore (₹1.56 lakh crore) with 98 per cent increase in new SIP account to 42.87 lakh (21.65 lakh) in FY24.

Palka Arora Chopra, Director, Master Capital said one of the drivers behind new investor additions is the adoption of SIP which allows investors to contribute a fixed amount at regular intervals, rather than pumping in a lump-sum in one go.

Use of online mode to reach out to the young investors and Gen Z in rural areas to tap the equity market through small SIPs of as low as ₹500 per month has made MF investments more inclusive and appealing to a broader segment of the population, especially first-time investors, said Chopra.

While market conditions may impact investor sentiment, low penetration amid the inherent strengths of SIPs, such as discipline, convenience and long-term wealth-building potential are likely to sustain the momentum of new investor additions in the years to come, she said.

Also read:Why this conservative hybrid fund makes sense amidst market volatilityRiding on the bull run, the investment attracted by the industry through new fund offer increased nine per cent last fiscal to ₹68,038 crore against ₹62,342 crore in FY23. Interestingly, equity remained the core theme of NFOs. Of the overall NFO flows, 89 per cent or ₹60,336 crore of the schemes were on equity.

Like (0)
Previous April 29, 2024 4:08 pm
Next April 29, 2024 4:08 pm

Related posts

  • FPIs turn buyers, snap 11-session selling streak

    Foreign portfolio investors turned buyers on Friday for the first time in May, snapping a 11-session selling streak that saw a selloff of over ₹37,000 crore in the cash market.

    stock options May 19, 2024
  • Jingzhida (688627.SH): Net profit will increase by 75.1% to 116 million yuan in 2023, and 10 units are planned to be 3.72 yuan

    Gelonghui April 25 | Jingzhida (688627.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 649 million yuan, a year-on-year increase of 28.53%; the net profit attributable to shareholders of the listed company was 116 million yuan. , a year-on-year increase of 75.10%. As of the end of the reporting period, the company\’s total assets were RMB 1,996,487,500, and its net assets attributable to shareholders of the listed company were RMB 1,719,227,500. Its financial position was sound. It is planned to distribute a cash dividend of 3.72 yuan (tax included) to all shareholders for every 10 shares.

    stock options April 25, 2024
  • Hyundai Motor shares hit record high as investors bet on India IPO plan

    Hyundai Motor Co's shares hit a record high as investors bet on the South Korean automaker's plan to list its India unit in Mumbai, which would help the company boost its presence in the world's third biggest auto market.

    stock options June 18, 2024
  • Crazy rising tide! Multiple stocks surged by 20%, and the A-share market suddenly became popular!

    Original Securities Times Mao Jun Today, A-shares fluctuated slightly, the main board market as a whole rose slightly, and the GEM and Science and Technology Innovation Board adjusted slightly. Affected by the fact that annual and quarterly report disclosures are coming to an end, investors are obviously less willing to trade in order to avoid performance landmines. Transactions in the two cities shrank again to 777.9 billion yuan, a new low in the past three months. On the market, the chemical industry, titanium metal, medicine, warehousing and logistics sectors were among the top gainers, while communication equipment, media and entertainment, aviation, humanoid robots and other sectors were among the top losers. In terms of funds, Wind real-time monitoring data shows that the basic chemical industry and pharmaceutical and biological industries both received a net inflow of more than 2 billion yuan today, while banks, power equipment, electronics, and transportation received a net inflow of more than 1 billion yuan. The net outflow of major funds in the national defense industry and computers exceeded 1 billion yuan. Regarding the market outlook,…

    stock options April 25, 2024
  • Glenmark, BeiGene team up to introduce advanced cancer therapies in India; stock trade flat

    Glenmark Pharmaceuticals Ltd.’s subsidiary Glenmark Specialty S.A., entered a marketing and distribution agreement with BeiGene, a global oncology company. This partnership will see Glenmark handle the local development, registration, and distribution of BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib, in India. Tislelizumab, an anti-PD-1 monoclonal antibody, is approved for advanced esophageal squamous cell carcinoma, among other cancers, while Zanubrutinib, a BTK inhibitor, is used for certain hematological malignancies.

    stock options May 22, 2024
  • Microsoft will invest $3.2 billion in Sweden to strengthen AI and cloud service facilities

    Sina Technology News on the afternoon of June 3rd, Beijing time, Microsoft plans to invest US$3.2 billion in artificial intelligence AI and cloud service facilities in Sweden, which is its largest infrastructure investment in the history of this Nordic country.

    stock options June 3, 2024